The Prescription Digital Therapeutics (PDT) Market Size is valued at USD 4.41 billion in 2023 and is predicted to reach USD 21.18 billion by the year 2031 at a 22.41% CAGR during the forecast period for 2024-2031.
Software-based therapies are one type of prescription digital medicine that is used to treat a variety of ailments. To create digital prescription drugs, biology and technology are merged. Many algorithms, virtual reality, and artificial intelligence were used in the creation of these therapeutic tools. Digital therapies, sometimes known as prescription PDTs, are a relatively new class of drugs. For serious illnesses like conventional biologics or drugs, PDTs work as direct therapy. A significant aspect influencing the growth rate of prescription digital therapeutics (PDT) throughout the projected period is the rise in the prevalence of chronic illnesses.
The increasing cost of healthcare, which contributes to the development of the industry's infrastructure, is another important element impacting the prescription digital therapeutics (PDT) market growth rate. Additionally, by boosting funding, a number of government groups hope to strengthen the healthcare infrastructure, which would further alter the dynamics of the market.
The prescription digital therapeutics (PDT) market is segmented based on type, application, and software. Based on type, the market is segmented into medication augmentation and medication replacement. By application, the market is segmented into children and adults. Based on software, the market is segmeneted into software for respiratory conditions, software for mental health, software for opioid use disorder, software for diabetes, and others. Based on services, the market is segmeneted into behavioral microservices, and medical microservices.
The medication augmentation category is expected to hold a major global market share in 2023. PDTs have become more widely used and more successful as a result of developments in digital health technology and the growing popularity of mobile health applications. This is especially true when it comes to augmenting the efficacy of conventional drugs. Digital solutions that can offer behavioural interventions, individualized feedback, and real-time monitoring are integrated into this category to improve patient outcomes and adherence. Medication augmentation PDT development and implementation are also being accelerated by regulatory approvals and pharmaceutical firms' increasing investments in digital technologies.
The rising incidence of severe diseases like diabetes, mental health issues, and cardiovascular ailments is driving the need for PDTs' cutting-edge therapy options. By providing individualized, evidence-based treatments that are easily accessible via digital platforms, these therapies improve patient adherence and results. Furthermore, PDTs are becoming more effective and personalized as a result of the use of cutting-edge technology like artificial intelligence and machine learning.
The North American prescription digital therapeutics (PDT) market is expected to report the maximum market revenue share in the near future because medical care has risen in quality. It is possible to generate fresh ideas for expanding the business in this location due to the abundance of resources. Due to its ability to create and autonomously execute the newest ideas, the region is dominant due to technical advancement. The area's large company base and advancing technological capabilities are further factors driving this sector's expansion. In addition, Asia Pacific is estimated to extend in the global prescription digital therapeutics (PDT) market. This is because the cost of healthcare is growing, and the frequency of chronic illnesses is rising as well, which will accelerate the market's growth rate in this area. Additionally, during the projected period in this region, growing investment in the development of cutting-edge technologies and an increase in the number of new markets would present favourable chances for the expansion of prescription digital therapeutics (PDT).
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 4.41 Bn |
|
Revenue Forecast In 2031 |
USD 21.18 Bn |
|
Growth Rate CAGR |
CAGR of 22.41% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, Application, Software and Services |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Akili Interactive, Better Therapeutics, Pear Therapeutics, ResMed, Biofourmis, Novartis, Medtronic, GAIA, Solera Network, BigHealth, Voluntis, Omada Health, Click Therapeutics, Naturalcycles Nordic, Happify, Limbix Health, NuvoAir, Sensyne Health, and Xealth. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Prescription Digital Therapeutics (PDT) Market Snapshot
Chapter 4. Global Prescription Digital Therapeutics (PDT) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Medication Augmentation
5.2.2. Medication Replacement
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Children
6.2.2. Adults
Chapter 7. Market Segmentation 3: by Software Estimates & Trend Analysis
7.1. by Software & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Software:
7.2.1. Software for Respiratory Conditions
7.2.2. Software for Mental Health
7.2.3. Software for Opioid Use Disorder
7.2.4. Software for Diabetes
7.2.5. Others
Chapter 8. Market Segmentation 4: by Services Estimates & Trend Analysis
8.1. by Services & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Services:
8.2.1. Behavioral Microservices
8.2.2. Medical Microservices
Chapter 9. Prescription Digital Therapeutics (PDT) Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.1.2. North America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.1.3. North America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Software, 2024-2031
9.1.4. North America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Services, 2024-2031
9.1.5. North America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.2.2. Europe Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.2.3. Europe Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Software, 2024-2031
9.2.4. Europe Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Services, 2024-2031
9.2.5. Europe Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.3.2. Asia Pacific Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.3.3. Asia Pacific Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Software, 2024-2031
9.3.4. Asia Pacific Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Services, 2024-2031
9.3.5. Asia Pacific Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.4.2. Latin America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.4.3. Latin America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Software, 2024-2031
9.4.4. Latin America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Services, 2024-2031
9.4.5. Latin America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.5.2. Middle East & Africa Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.5.3. Middle East & Africa Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Software, 2024-2031
9.5.4. Middle East & Africa Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Services, 2024-2031
9.5.5. Middle East & Africa Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Akili Interactive
10.2.2. Pear Therapeutics
10.2.3. Better Therapeutics
10.2.4. ResMed
10.2.5. Biofourmis
10.2.6. Novartis
10.2.7. Medtronic
10.2.8. Voluntis
10.2.9. Omada Health
10.2.10. GAIA
10.2.11. Solera Network
10.2.12. BigHealth
10.2.13. Click Therapeutics
10.2.14. Happify
10.2.15. Limbix Health
10.2.16. Naturalcycles Nordic
10.2.17. NuvoAir
10.2.18. Sensyne Health
10.2.19. Xealth
10.2.20. Other Prominent Players
Prescription Digital Therapeutics (PDT) Market By Type-
Prescription Digital Therapeutics (PDT) Market By Application-
Prescription Digital Therapeutics (PDT) Market By Software
Prescription Digital Therapeutics (PDT) Market By Services
Prescription Digital Therapeutics (PDT) Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
